Nail Lichen Planus: Successful Treatment with Etanercept
Background: Etanercept is a fully human tumor necrosis factor α receptor fusion protein that binds tumor necrosis factor α with greater affinity than natural receptors. Biologics are widely used in the treatment of psoriasis and psoriasis arthritis and may represent a new therapeutic option for some...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2010-10-01
|
Series: | Case Reports in Dermatology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/321419 |
id |
doaj-7b7417178a4d465da626906d11ac0547 |
---|---|
record_format |
Article |
spelling |
doaj-7b7417178a4d465da626906d11ac05472020-11-24T23:40:21ZengKarger PublishersCase Reports in Dermatology1662-65672010-10-012317317610.1159/000321419321419Nail Lichen Planus: Successful Treatment with EtanerceptN. IrlaT. SchneiterE. HanekeN. YawalkarBackground: Etanercept is a fully human tumor necrosis factor α receptor fusion protein that binds tumor necrosis factor α with greater affinity than natural receptors. Biologics are widely used in the treatment of psoriasis and psoriasis arthritis and may represent a new therapeutic option for some patients with psoriatic nail disease. Case Report: We report a case of lichen planus limited to the toe nails successfully treated with etanercept monotherapy. Conclusion: The significant improvement of our case suggests that etanercept is an effective treatment modality for lichen planus limited particularly to the nails. Further controlled studies are needed to establish the effectiveness and therapeutic regimes.http://www.karger.com/Article/FullText/321419Nail lichen planusTreatmentBiologicsEtanercept |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
N. Irla T. Schneiter E. Haneke N. Yawalkar |
spellingShingle |
N. Irla T. Schneiter E. Haneke N. Yawalkar Nail Lichen Planus: Successful Treatment with Etanercept Case Reports in Dermatology Nail lichen planus Treatment Biologics Etanercept |
author_facet |
N. Irla T. Schneiter E. Haneke N. Yawalkar |
author_sort |
N. Irla |
title |
Nail Lichen Planus: Successful Treatment with Etanercept |
title_short |
Nail Lichen Planus: Successful Treatment with Etanercept |
title_full |
Nail Lichen Planus: Successful Treatment with Etanercept |
title_fullStr |
Nail Lichen Planus: Successful Treatment with Etanercept |
title_full_unstemmed |
Nail Lichen Planus: Successful Treatment with Etanercept |
title_sort |
nail lichen planus: successful treatment with etanercept |
publisher |
Karger Publishers |
series |
Case Reports in Dermatology |
issn |
1662-6567 |
publishDate |
2010-10-01 |
description |
Background: Etanercept is a fully human tumor necrosis factor α receptor fusion protein that binds tumor necrosis factor α with greater affinity than natural receptors. Biologics are widely used in the treatment of psoriasis and psoriasis arthritis and may represent a new therapeutic option for some patients with psoriatic nail disease. Case Report: We report a case of lichen planus limited to the toe nails successfully treated with etanercept monotherapy. Conclusion: The significant improvement of our case suggests that etanercept is an effective treatment modality for lichen planus limited particularly to the nails. Further controlled studies are needed to establish the effectiveness and therapeutic regimes. |
topic |
Nail lichen planus Treatment Biologics Etanercept |
url |
http://www.karger.com/Article/FullText/321419 |
work_keys_str_mv |
AT nirla naillichenplanussuccessfultreatmentwithetanercept AT tschneiter naillichenplanussuccessfultreatmentwithetanercept AT ehaneke naillichenplanussuccessfultreatmentwithetanercept AT nyawalkar naillichenplanussuccessfultreatmentwithetanercept |
_version_ |
1725509905901682688 |